An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)

Conditions:   Acute Lymphoblastic Leukemia;   Lymphoblastic Leukemia Interventions:   Drug: IM JZP-458;   Drug: IV JZP-458 Sponsors:   Jazz Pharmaceuticals;   Children's Oncology Group (COG) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials